Not sure where you got that info . from E13 but the CEO certainly has not been overseas in the last week ..But I can say Teva is re-arranging its board I have not looked at the changes, but I am told there are no adverse effects to any of MSB,s contracts .. On a previous post " Excellent news for MSB " that news puts our company well in front of many listed companys world wide, and hundreds of unlisted and "cowboy outfits " as the medical profesion descibes them ...Some of these groups take advantage of the incureable without going thru the FDA system ...The FDA have progressed some issues to look after the real stem cell companys they have set up an expedient (urgent) system to ensure once the trials have been successful, next steps will be addressed quickly to ensure lives are saved and major health issues dealt with immeadiately ..... Vin
share price, page-8
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |